You are on page 1of 22

Dr.

Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

Key Skills

 Clinical Research, Medical Writing, Clinical Evaluation Report, Literature Search Report,
Device safety and efficacy evaluation, Clinical Trial Management, TAVI, TAVR Core Lab,
Scaffold, DCB, Total Knee Replacement, GCP Audit, Clinical Affairs, Product
Management, ISO 14155, ISO 13485, ISO14971, ISO 5840, ISO 10993, QCA and ECG
Core-Lab, ICH-GCP, CE submission, Clinical Marketing, Regulatory writing, PMCF,
PMS.

Experience on following Device Trials


 Coronary Stent, Scaffold, Drug-Coated Balloons, Self-Expandable Nitinol Stent, Heart
Valve, Guide Wire, Knee Replacement, Hip Replacement, Suture, PPH Stapler, IUDs,
Blood Glucometer and Vascular Closure Device.

PROFESSIONAL EXPERIENCE

Employer Name: Meril Life Sciences Pvt. Ltd., Vapi, Gujarat (Jan 2016- present)
Designation: Head – Clinical Research (Senior General Manager)

Role and Responsibilities: Medical writing, Design and monitoring of clinical trials etc.
 Mentors and coaches all levels of Project Management.
 Monitoring the trial progress to ensure compliance with and adherence to the project plan and
to identify, evaluate and rectify problems.
 Provision of regular and ad hoc information, both written and verbal, to all the trial participants
and sponsors, to include reports, updates, guidance, preformed commitments and, possibly, a
Newsletter.
 Planning and supporting the meetings and work of the various groups and bodies associated
with the trial.
 Leads, directs and executes clinical studies and/or programs worldwide in accordance with
strategy, project plans, approved budget and resource allocations following applicable
regulatory and standard operating procedures.
 Meeting with the key Doctors and discuss about scope of publications and studies
 To discuss with the Doctors about how MLS’s clinical data and their own data can be published

Employer Name: Sahajanand Medical Technologies Pvt. Ltd., Surat, Gujarat (Nov2007- Dec 2015)
Designation: Senior Manager – Clinical Research and Medical Writing

Role and Responsibilities: Medical writing, Literature review, Design and monitoring of clinical
trials, Clinical marketing etc.
 Mentors and coaches all levels of Project Management.
 Monitoring the trial progress to ensure compliance with and adherence to the project plan and
to identify, evaluate and rectify problems.

Page 1 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

 Provision of regular and ad hoc information, both written and verbal, to all the trial participants
and sponsors, to include reports, updates, guidance, preformed commitments and, possibly, a
Newsletter.
 Planning and supporting the meetings and work of the various groups and bodies associated
with the trial.
 Leads, directs and executes clinical studies and/or programs worldwide in accordance with
strategy, project plans, approved budget and resource allocations following applicable
regulatory and standard operating procedures.
 Meeting with the key Doctors and discuss about scope of publications and studies
 To discuss with the Doctors about how SMT’s clinical data and their own data can be published

Employer Name: Central Drugs Standards Control Organization (CDSCO) (June 2011 – Dec 2011)
Designation: Medical Device Consultant

Role and Responsibilities:


● To collect, compile and analyse the scientific national, international data/regulation of medical devices.
● To make relevant SOP’s, guidelines and notification for amendments in Schedule M-III and M-IV to
Drugs & Cosmetics Rules.
● Any other duties assigned by Drugs Controller General of India (DCGI) from time to time

Employer Name: Vibgyor Scientific Research Pvt. Ltd., Ahmedabad, Gujarat (Aug 2006 –Nov2007)
Designation: Site Manager – Clinical Studies

Role and Responsibilities:

 Monitoring and management of all stages of clinical research


 Development and review and assessment of clinical research documents and tools (Protocols, Informed
Consent Forms, Case Report Forms, Questionnaires etc.) for compliance with applicable standards and
regulations
 Development, review and assessment of internal systems/processes, standard operating procedures and
working practice documents for compliance with applicable standards and regulations
 Development and quality check of documents summarizing the requirements for clinical trials in
specific regions/countries
 Conduct of sponsors, CROs, sites and vendors GCP Audits, training clinical research personnel
(sponsor/CRO and research sites teams)

Employer Name: GlaxoSmithKline Pharma Ltd., Ahmedabad, Gujarat (Jan 2003 - Nov 2004)
Designation: Medical Representative

Role and Responsibilities:

● Promoting products to doctors and generating sales through prescriptions and scientific discussions.
● Achieving the sales target assigned for the given territory, conduct CMEs and activities as defined in cycle
meetings

Page 2 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

Employer Name: Macleods Pharma Ltd., Mahesana, Gujarat, India (July 2002 - Dec 2002)
Designation: Medical Representative

Role and Responsibilities:

● Promoting products to Doctors and generating sales through prescriptions and scientific discussions.
● Achieving the sales target assigned for the given territory, conduct CMEs and activities as defined in cycle
meetings

 INTERNATIONAL AND NATIONAL CLINICAL TRIALS MANAGED

 Project Manager for Supralimus-Core FIM Study (MAXIMUS), Supralimus-Core Recoil Study,
Supralimus-Core pharmacokinetic Study, E-SERIES Registry and Infinnium-Core™ Registry.
Sponsor: Sahajanand Medical Technologies Pvt. Ltd.

 Team Member for a B1461001: Prospective Randomized Phase IV Open Label Comparative Study of
Tranexamic Acid plus Standard of Care Vs Standard of Care for the Reduction of Blood Loss in Patients
undergoing Major abdominal Surgery. Sponsor: Pfizer

 Team Member for Clopidogrel in MI study: An international, randomized, double blind, double dummy
trial (OASIS 7). Sponsor: Sanofi-Aventis Pharma

 Study Team member for a trial of Abciximab study:


Sponsor: Lupin Pharma. Ltd.

 Study team member of Polycap Trial


Sponsor: Cadila Pharma. Ltd.

 Study team member of Bivaflo Registry


Sponsor: Sun Pharma. Ltd.

 Team member for Phase III Study in MI (Plato Study).


Sponsor: Astra-Zeneca

 Team member of a Protect study.


Sponsor: Medtronic

 Team member of a e-Cypher study


Sponsor: Cordis, Johnson & Johnson

 Team member of Export study


Sponsor: Medtronic

 Scientific Publications and Events:


 Author in scientific papers, International Indexed Journal (67)
 Author in scientific papers, National Indexed Journal (21)

Page 3 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

 Oral Presentations/Poster Presentations in National/International Conferences (12)


 First Author in Publications (5)

 Publication Summary
 European Medical Journal (1)
 Journal of The American College of Cardiology (1)
 European Heart Journal (2)
 Cardiovascular Diagnosis and Therapy (3)
 Minerva Cardioangiologica (1)
 International Journal of Clinical Medicine (15)
 Indian heart journal (4)
 Indian Journal of Medical Research (1)
 International Journal of Stroke(2)
 Journal of Clinical and Diagnostic Research (8)
 EuroIntervention: journal of EuroPCR in collaboration (11)
 Catheterization and Cardiovascular Intervention (8)
 British Journal of Medicine and Medical Research (4)
 Journal of Cardiology and Therapeutics (6)
 BMJ Case Reports (4)
 Indian Journal of Phamracology (2)
 Journal of pharmacovigilance and drug safety (1)
 World Journal of Cardiology (2 )
 Journal of Invasive Cardiology (1)
 Journal of Medical Devices (1)
 Journal of Association Physicians India (1)
 Journal of Cardiology Cases (1)
 Interventional Cardiology (1)
 Glimpses of Medicine (1)
 Heart India (1)
 Cardiology (Karger Medical and Scientific Publishers) (1)
 International Journal of Vascular Medicine (1)
 Scientifica (1)
 International Journal of Clinical Trials (1)

Page 4 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

 Cardiology Research (3)

 PUBLICATIONS IN INTERNATIONAL JOURNALS (65 publications)


Sr. Titles ISSN / ISBN Publisher Volume/Page Year
No.
No /DOI
1 Clinical Outcomes of Novel ISSN-print: 1923- Cardiology 2018;9(6):350-357 2018
Long-Tapered Sirolimus-Eluting 2829 Research https://doi.org/1
Coronary Stent System in Real- ISSN-online: 0.14740/cr795
World Patients with Long 1923-2837
Diffused De Novo Coronary
Lesions
2 Pharmacokinetic Study of ISSN-print: 1923- Cardiology 2018;9(6):364-369 2018
Sirolimus-Eluting BioResorbable 2829 Research https://doi.org/1
Vascular Scaffold System for ISSN-online: 0.14740/cr799
Treatment of De Novo Native 1923-2837
Coronary Lesions: A Sub-Study of
MeRes-1 Trial
3 Clinical Outcomes of World’s ISSN-print: 1923- Cardiology 2018;9(6):370-377 2018
Thinnest (50 μmr) Strut https://doi.org/10.14
2829 Research 740/cr800
Biodegradable Polymer Coated ISSN-online:
Everolimus-Eluting Coronary 1923-2837
Stent System in Real-World
Patients
4 Clinical outcomes of ultrathin ISSN: 1774-024X EuroInterventio https://abstractb 2018
strut biodegradable polymer- (print), 1969- n ook.pcronline.co
coated everolimus-eluting 6213 (online) m/export/pdf/id/
coronary stent system in treatment 100587
of patient with de novo coronary
artery lesions
5 Multicentre clinical outcomes of ISSN: 1774-024X EuroInterventio https://abstractb 2018
hybrid tapered sirolimus-eluting (print), 1969- n ook.pcronline.co
coronary stent 6213 (online) m/export/pdf/id/
system with biodegradable 100414
polymer in long diffuse de novo
coronary artery lesions
6 Evaluation of safety and efficacy Print ISSN:2349- International Volume 5, No 1 2018
of polyglactin 910 suture in 3240 Journal of (2018)
surgical incision closure: clinical Online Clinical Trials 10.18203/2349-
study protocol for a randomized ISSN:2349-3259 3259.ijct2018013
controlled trial 5
7 Revolution of Drug-Eluting ISSN: 2397-6764 European 4[1]:114-125 2016
Coronary Stents An Analysis of Medical Journal
Market Leaders
8 Clinical Outcomes from ISSN: 2090-908X Scientifica Volume 2015 2015

Page 5 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

Unselected “Real-World” Patients (2015)


with Long Coronary Lesion 10.1155/2015/61
Receiving 40 mm Biodegradable 3089
Polymer Coated Sirolimus-Eluting
Stent
9 Clinical Outcomes of ISSN: 0735-1097 Journal of The Volume 66, Issue 2015
Biodegradable-Polymer Coated American 15_S, October
Sirolimus-Eluting Stent in College of 2015
Unselected Patients with Long Cardiology doi:
Coronary Lesions: LONG-FLEX 10.1016/j.jacc.20
Registry 15.08.1041
10 Analysis of Trends of Sleep- ISSN(Print): International 6(8):561-569, 2015
Related Breathing Disorders in 20902824, Journal of doi:
Patients with Systemic Essential e-ISSN: Clinical 10.4236/ijcm.201
Hypertension 20902832 Medicine 5.68075
11 Clinical outcomes of successful Electronic ISSN. European Heart Volume 36, Issue 2015
percutaneous coronary 1522-9645, Print Journal suppl 1, 828-9;
intervention for chronic total ISSN. 0195-668X 1 August 2015
occlusion treated with sirolimus-
eluting stent: results from the
multicenter CTO registry
12 In-hospital, thirty-day and six- Electronic ISSN. European Heart Volume 36, Issue 2015
month result of biodegradable 1522-9645, Print Journal suppl 1, 827;
polymer coated sirolimus eluting ISSN. 0195-668X 1 August 2015
stent in coronary artery lesions (i-
TRIAL study)
13 Favorable Outcomes after ISSN(Print): International Volume 2015 2015
Implantation of Biodegradable 20902824, Journal of (2015), Article ID
Polymer Coated Sirolimus-Eluting e-ISSN: Vascular 265670, 5 pages
Stents in Diabetic Population: 20902832 Medicine dx.doi.org/10.115
Results from INDOLIMUS-G 5/2015/265670
Diabetic Registry
14 Overcoming Double Trouble in ISSN Print: 2158- International 6(8):586-590, 2015
Single-Sitting: 284X Journal of dx.doi.org/10.423
A Case of an 8-Year-Old Boy with e-ISSN: 2158- Clinical 6/ijcm.2015.6807
Coarctation 2882 Medicine 8
of Aorta and Patent Ductus
Arteriosus
15 Link between Friesinger Index ISSN Print: 2158- International 6(8):538-546, 2015
and Lipid Profile in Patients 284X Journal of 10.4236/ijcm.201
Undergoing Diagnostic e-ISSN: 2158- Clinical 5.68072
Coronary Angiography 2882 Medicine

16 Long term clinical outcomes ISSN: 0008-6312 Cardiology 10.1159/0004347 2015


following sirolimus-eluting (Print) (Karger Medical 07
stent implantation in diabetic e-ISSN: 1421- and Scientific
vs. non-diabetic patients 9751 (Online) Publishers)
17 Recanalization of chronic total ISSN: 1179-8475 Research 2015

Page 6 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

occlusion lesions: a critical Reports in


appraisal of current devices and Clinical
techniques Cardiology
18 Evaluation of prolonged safety Print ISSN: 2223- Cardiovascular 2015, 5(4):249- 2015
and efficacy of biodegradable 3652; Online Diagnosis and 25,
polymer coated sirolimus-eluting ISSN: 2223-3660 Therapy doi:
coronary stent system: 1-year 10.3978/j.issn.22
outcomes of the Indolimus 23-
registry 3652.2015.04.07
19 Evaluation of clinical and ISSN: 1774-024X EuroInterventio http://www.pcro 2015
angiographic outcomes with (print), 1969- n nline.com/euroint
bioabsorbable polymer coated 6213 (online) ervention/Abstrac
sirolimus-eluting stent in de novo tsEuroPCR2015/P
coronary artery disease: results of OS092/
the MANIPAL-FLEX first-in-man
study
20 In-hospital, thirty-day and six- ISSN: 1774-024X EuroInterventio http://www.pcro 2015
month result of biodegradable (print), 1969- n nline.com/euroint
polymer coated 6213 (online) ervention/Abstrac
sirolimus eluting stent in coronary tsEuroPCR2015/O
artery lesions (i-TRIAL study) P044/
21 Clinical outcomes after ISSN: 1774-024X EuroInterventio http://www.pcro 2015
implantation of bioabsorbable (print), 1969- n nline.com/euroint
polymer coated sirolimuseluting 6213 (online) ervention/Abstrac
stent in multivessel stenting: 6- tsEuroPCR2015/P
month follow-up data from the OS136/
MULTIDOS study
22 Clinical outcomes from ISSN: 1774-024X EuroInterventio http://www.pcro 2015
unselected real-world patients (print), 1969- n nline.com/euroint
with long coronary lesion 6213 (online) ervention/Abstrac
receiving 40 mm bioabsorbable tsEuroPCR2015/O
polymer coated sirolimus-eluting P018/
stent
23 Evaluation of thienopyridine- Print ISSN: 1522- CCI, Wiley, USA 10.13140/2.1.478 2015
resistance by measuring platelet 1946 5.7448
aggregation in individuals taking Online ISSN:
antiplatelet drugs post-PCI: 1522-726X
Outcomes with a novel, FDA-
approved, point-of-care platelet
aggregometer “AggreGuide A-
100”
24 One-year outcomes of Print ISSN: 1522- CCI, Wiley, USA 10.13140/2.1.347 2015
Biodegradable Polymer-Coated 1946 5.0242
Sirolimus-Eluting Coronary Stent Online ISSN:
System in Real-world Setting: 1522-726X
Findings of Indolimus Registry
25 Safety and efficacy of coronary Print ISSN: 1522- CCI, Wiley, USA 10.13140/2.1.242 2015
intervention in patients with Acute 1946 6.4487
Myocardial Infarction: Outcomes Online ISSN:

Page 7 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

of Sirolimus-eluting stent in “All- 1522-726X


comers” Lesion Treatment
26 Clinical performance of P.ISSN 0026-4725 MINERVA 10.1186/s12940- 2015
biodegradable polymer coated E.ISSN 1827- CARDIOANGIOL 015-0004-0
sirolimus eluting stents in 1618 OGICA
unselected "real-world"
population with coronary artery
disease - results from multi-
centre core registry.
27 Non-identical yet similar: Print ISSN: 2223- Cardiovascular 5(2):145-14 2015
presentation of coronary artery 3652; Online Diagnosis and 10.3978/j.issn.22
disease in dizygotic twins ISSN: 2223-3660 Therapy 23-
3652.2015.01.11

28 Accessory pancreatic lobe with ISSN: 1757-790X BMJ Case 10.1136/bcr- 2015
gastric duplication Reports 2014-207751
cyst: diagnostic challenges of a
rare congenital
anomaly
29 Prolapse of all cardiac valves in ISSN: 1757-790X BMJ Case 10.1136/bcr- 2015
Noonan syndrome Reports 2014-207241
30 A Preoperative Requisite in ISSN: 2231-0614 British Journal 6(7):730-734 2015
Patients with Juvenile of Medicine and
Nasopharyngeal Angiofibroma: Medical 10.9734/BJMMR/
Report of Three Patients Research 2015/14452
31 Sinus Node Ischemia- A unique ISSN Print: 2158- International 6(1):50-54 2015
presentation 284X Journal of
e-ISSN: 2158- Clinical
2882 Medicine

32 Percutaneous Intervention in ISSN Print: 2158- International 6(1):55-59 2015


Kyphoscoliosis - Tackling a 284X Journal of
Tortuosity e-ISSN: 2158- Clinical
2882 Medicine
33 Conduction disturbances after ISSN: 1774-024X EuroInterventio May, 2014 2014
perimembranous ventricular (print), 1969- n
septal defect device closure in 6213 (online)
young children with significant
left to right shunt: a
prospective study
34 Usefulness of GuideLiner ISSN: 2311-052X Journal of 2:96-104 2014
Catheter during Percutaneous Cardiology and
Coronary Intervention in Therapeutics
Difficult to Cross Complex
Lesions due to Calcification
and Tortuosity

Page 8 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

35 Acute Stroke Management ISSN: 1747-4949 International 9(3);94 2014


Outcome after decompressive Journal of
craniectomy in patients with Stroke
ischemic stroke
36 A single center experiece of ISSN: 1747-4949 International 9(3);200 2014
carotid artery stenting without Journal of
protection devices for the Stroke
treatment of obstructive
extracranial carotid artery
disease
37 Diagnostic accuracy of ISSN: 1774-024X EuroInterventio May, 2014 2014
different diagnostic methods (print), 1969- n
for tetralogy of Fallot patients 6213 (online)
prior to biventricular repair
38 Successful non-surgical ISSN: 1755-5310 Interventional 6(5):411–414 2014
management of entrapped Cardiology
hydrophilic guidewire during
percutaneous coronary
intervention
39 Double Intervention in Single ISSN Print: 2158- International 5(20):1311-1315 2014
Sitting: Percutaneous Device 284X Journal of
Closure and Permanent e-ISSN: 2158- Clinical
Pacemaker Implantation in a 2882 Medicine
Patient with Atrial Septal
Defect
40 Clinical performance of the Print ISSN: 1522- Catheterization 83(S1):S180 2014
cobalt-chromium 1946 and
biodegradable polymer coated Online ISSN: Cardiovascular
sirolimus-eluting stent in an 1522-726X Interventions
unselected real-world
population
41 Clinical outcomes from ISSN:1522-726X Catheterization 83(S1);S180 2014
unselected real‐world patients and
with acute myocardial Cardiovascular
infarction Interventions
receiving biodegradable
polymer coated sirolimus‐
eluting stents
42 Comparative conformability of ISSN: 1774-024X EuroInterventio May, 2014 2014
two cobalt-chromium stents (print), 1969- n
with different stents design and 6213 (online)
strut thickness
43 Coronary steal or large collateral? ISSN: 1757-790X BMJ Case Nov, 2014 2014
Three cases of graft failure in Reports
sequential and composite grafts
44 Successful Percutaneous ISSN Print: 2158- International 5(20):1265-1268 2014

Page 9 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

Treatment of Coronary Artery 284X Journal of


Ectasia with Drug-Eluting Stent e-ISSN: 2158- Clinical
2882 Medicine
45 Cardiac Dysfunction in Patients ISSN: 2231-0614 British Journal 5(4):427-433 2014
with Sepsis, Severe Sepsis and of Medicine and
Septic Shock Medical
Research
46 Endovascular Y-stent Graft Repair ISSN: 2231-0614 British Journal 4(31):5074-82 2014
of Chronic Contained Ruptured of Medicine and
Abdominal Aortic Aneurysm in Medical
High-Surgical Risk Patient Research
47 Successful patent ductus ISSN: 1878-5409 Journal of 10(2):62-65 2014
arteriosus device closure in a Cardiology
patient with massive pulmonary Cases
embolism
48 Efficacy of Isovolumic ISSN Print: 2158- International 5(12):674-680 2014
Acceleration in Assessing 284X Journal of
Right Ventricular Function in e-ISSN: 2158- Clinical
Pulmonary Hypertension 2882 Medicine
49 Accelerated Atherosclerosis in a ISSN Print: 2158- International 5(10):541-545 2014
Young Female with Familial 284X Journal of
Hypercholesterolemia e-ISSN: 2158- Clinical
2882 Medicine
50 Percutaneous Coronary ISSN Print: 2158- International 5(10):567-571 2014
Intervention in Chronic Total 284X Journal of
Occlusion of Anomalous Right e-ISSN: 2158- Clinical
Coronary Artery 2882 Medicine
51 Safety and Efficacy of Sirolimus- ISSN: 2311-052X Journal of 2:21-26 2014
Eluting Stent in Diabetic Patients Cardiology and
Compared with Non-Diabetic Therapeutics
Patients Undergoing Percutaneous
Coronary Intervention
52 Clinical Profile and in-hospital ISSN Print: 2158- International 5(8):459-463 2014
outcome of patients with right 284X Journal of
ventricular myocardial e-ISSN: 2158- Clinical
infarction 2882 Medicine
53 A real world experience of ISSN Print: 2158- International 5(8):475-481 2014
guide wire induced perforations 284X Journal of
during percutaneous e-ISSN: 2158- Clinical
intervention and their 2882 Medicine
successful management
54 Comparison of two biodegradable ISSN: 2311-052X Journal of 2:12-20 2014
polymer coated, drug-eluting Cardiology and
coronary stents paclitaxel vs. Therapeutics
sirolimus, with 6-years clinical
follow-up: BIOPRESS
(BIOdegradable Polymer REgistry

Page 10 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

Smt Stents) Infinnium vs.


Supralimus
55 Effects of Statin Therapy on ISSN Print: 2158- International 5(4):149-156 2014
Endothelial Function in 284X Journal of
Asymptomatic Metabolic e-ISSN: 2158- Clinical
Syndrome 2882 Medicine
56 Acute effect of mobile phone on ISSN Print: 2158- International 5(5): 167-170 2014
cardiac electrical activity in 284X Journal of
healthy volunteers e-ISSN: 2158- Clinical
2882 Medicine
57 Clinical Profile and treatment ISSN Print: 2158- International 5(5):171-176 2014
management of heart failure with 284X Journal of
preserved systolic function in e-ISSN: 2158- Clinical
rural setting of India 2882 Medicine
58 Seven Years Follow-up of ISSN Print: 2158- International 5:216-224 2014
Biodegradable Polymer Coated 284X Journal of
Paclitaxel-Eluting Infinnium e-ISSN: 2158- Clinical
Coronary Stent in Saudi Arabia 2882 Medicine
59 Clinical performance of the ISSN Print: 2158- International 5:206-215 2014
cobalt-chromium biodegradable 284X Journal of
polymer coated sirolimus-eluting e-ISSN: 2158- Clinical
stent in an unselected real-world 2882 Medicine
population
60 Clinical spectrum of Infective ISSN Print: 2158- International 5(5): 177-187 2014
Endocarditis in a tertiary care 284X Journal of
centre in western India: a e-ISSN: 2158- Clinical
prospective study 2882 Medicine
61 Clinical outcomes from ISSN: 2311-052X Journal of 1:64-70 2014
unselected real-world patients Cardiology and
with acute myocardial infarction Therapeutics
receiving biodegradable polymer
coated sirolimus-eluting stents
62 Single Centre Experience and ISSN: 2311-052X Journal of 1:51-57 2014
Outcome of Primary Percutaneous Cardiology and
Coronary Intervention for patients Therapeutics
with ST-Segment-Elevation
Myocardial Infarction
63 Development and Evaluation of ISSN: 1932-6181 Journal of 7(1):011005- 2013
Drug Eluting Stent Having (print), 1932- Medical Devices 011005
Biphasic Release From a Single 619X (online)
Layer of Biodegradable Polymer
64 Safety and efficacy of the ISSN: 1042-3931 Journal of 25:344-347 2013
frontrunner xp catheter for (print), 1557- Invasive
recanalization of chronic total 2501 (online) Cardiology
occlusion of the femoropopliteal
arteries
65 A case of type I variant kounis ISSN: 1949-8462 World Journal of 5:112-114 2013
syndrome with samter-beer triad Cardiology

Page 11 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

66 Response of blood pressure after ISSN: 1949-8462 World Journal of 5:247-253 2013
percutaneous transluminal renal Cardiology
artery angioplasty and stenting
67 Clinical safety & efficacy study of ISSN: 1774-024X EuroInterventio 6:67 2010
Bivalirudin & its comparison with (print), 1969- n
Heparin in patients undergoing 6213 (online)
percutaneous coronary
intervention

 PUBLICATIONS IN NATIONAL JOURNALS (20 publications)


Sr. Titles ISSN / Publisher Volume/Page/DOI Year
No.
ISBN No
1 Basic Concepts and ISSN: 2249- Journal of Clinical 11(6); OE01 - OE04, 2017
Clinical Outcomes of 782X and Diagnostic 10.7860/JCDR/2015/14060.640
Drug-eluting Balloons (print), Research 3
for Treatment of 0973-709X
Coronary Artery (online)
Disease: An Overview
2 A Post-Marketing ISSN: 2249- Journal of Clinical 11(5); FC29 - FC32, 2017
Surveillance Study to 782X and Diagnostic 10.7860/JCDR/2017/26596.989
Evaluate Performance of (print), Research 2
the EXIMO™ Blood 0973-709X
Glucose Monitoring (online)
System
3 Small-for-gestational- ISSN: 0971- Indian Journal of 2016 Aug;144(2):194-199 2016
age versus appropriate- 5916 Medical Research 10.4103/0971-5916.195025
for-gestational-age:
Comparison of cord
blood lipid profile &
insulin levels in term
newborns (SAGA-ACT
study).
4 Clinical Performance of ISSN: Heart India Vol 4 / Issue 1 / Jan-Mar 2016 2016
Biodegradable Polymer Print -2321- Wolters Kluwer - 10.4103/2321-449X.178118
Coated Sirolimus 449X, Medknow
eluting Stent in Online -
Multivessel Disease: 2321-6638
Results
from MULTIDES Study
5 Necessity is the Mother ISSN: 2249- Journal of Clinical 10(2):OD14-5. doi: 2016
of Invention 782X and Diagnostic 10.7860/JCDR/2016/14926.723
(print), Research 2
0973-709X
(online)
6 Nine-Months Clinical ISSN: 2249- Journal of Clinical 9(8); OC23 – OC26, 2015
Outcome of 782X and Diagnostic 10.7860/JCDR/2015/14060.640

Page 12 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

Biodegradable (print), Research 3


Polymer Coated 0973-709X
Sirolimus-eluting (online)
Stent System: A Multi-
Centre “Real-World”
Experience
7 Prognosis of Left ISSN: 2249- Journal of Clinical 9(3); OC05 - OC08 2015
Ventricular Systolic 782X and Diagnostic
Dysfunction in Septic (print), Research
Shock Patients 0973-709X
(online)
8 Successful transradial ISSN: 2249- Journal of Clinical 9(1);OD04-OD05 2015
percutaneous coronary 782X and Diagnostic
intervention in a (print), Research
patient with 0973-709X
dextrocardia and situs (online)
inversus
9 Evaluation of Clinical ISSN: 2249- Journal of Clinical 9(2);OC05-OC09 2015
Outcomes in Patients 782X and Diagnostic
Undergoing Dual (print), Research
Vessel Percutaneous 0973-709X
Coronary Intervention (online)
Using Sirolimus-
Eluting Coronary
Stent System in India
10 Evaluation of subtle ISSN: 2249- Journal of Clinical 8(12):5-9 2014
left ventricular systolic 782X and Diagnostic
abnormalities in adult (print), Research
patients with 0973-709X
hypertrophic (online)
cardiomyopathy
11 Small for gestational ISSN: 0019- Indian Heart 66(2):S70 2014
age Vs. appropriate for 4832 Journal
gestational age:
Analytical comparison
of cord blood lipid
profiles and insulin
levels in term
newborns (SAGA-
ACT study)
12 Novel Atherosclerotic : 0004-5772 Journal of 62:576-580 2014
Risk Factors and Association
Angiographic Profile of Physicians India
Young Gujarati Patients
Presented with Acute
Coronary Syndrome

Page 13 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

13 Experience with ISSN: 2249- Journal of Clinical 7:1959-1963 2013


biodegradable polymer 782X and Diagnostic
coated sirolimus-eluting (print), Research
coronary stent system in 0973-709X
"real-life" percutaneous (online)
coronary intervention:
24-month data from the
manipal-s registry
14 Systemic exposure of ISSN: 1349- Indian Heart 64:273-279 2012
sirolimus after coronary 2365 Journal
stent implantation in (print),
patients with de novo 1349-3299
coronary lesions: (online)
Supralimus-core(r)
pharmacokinetic study
15 A first-in-man study of ISSN: 1349- Indian Heart 64:547-552 2012
sirolimus-eluting, 2365 Journal
biodegradable polymer (print),
coated cobalt chromium 1349-3299
stent in real life patients (online)
16 In vivo assessment of ISSN: 1349- Indian Heart 64:541-546 2012
stent recoil of 2365 Journal
biodegradable polymer- (print),
coated cobalt-chromium 1349-3299
sirolimus-eluting (online)
coronary stent system
17 Interpretation of Clinical Glimpses of VI, 18-37 2010
Trials Medicine
18 Development and ISSN: Print Indian Journal of 41(1), S157 2009
evaluation of novel -0253-7613, Pharmacology
biocompatible and Online -
biodegradable sirolimus 1998-3751
eluting stent having
biphasic release profile
19 Comparative study of ISSN: Print Indian Journal of 41(1), S36 2009
different stents on -0253-7613, Pharmacology
clinical outcomes Online -
following coronary 1998-3751
stenting
20 The risk of stent ISSN:0972- Journal of 5 (1); 65-72 2008
thrombosis and 8899 Pharmacovigilanc
antiplatelet therapy e and Drug Safety
21 The short-term and long- ISSN: Print Indian Journal of 40 (2);S200 2008
term clinical outcomes -0253-7613, Pharmacology
following coronary Online -
stenting 1998-3751

Page 14 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

 Oral Presentations/Poster Presentations in National/International Conferences (16 Oral/Poster


presentations)
Sr. Titles Name of Country DOI Year
No. Conference
1 Outcomes of Ultrathin Strut TCT 2018 USA 2018
Biodegradable Polymer
Coated Everolimus-Eluting
Coronary Stent in Patients
With Coronary Artery
Disease
2 Two-Year Outcomes of TCT 2018 USA 2018
Biodegradable Polymer
Coated Sirolimus-Eluting
Coronary Stent System in
Patients With Coronary
Artery Disease
3 Treatment With Long- TCT 2018 USA 2018
Tapered Sirolimus-Eluting
Coronary Stent System:
Clinical Outcomes in
Patients With Long Diffuse
De Novo Coronary Artery
Lesions
4 Clinical Outcomes of TCT 2015 USA 2015
Biodegradable-Polymer
Coated
Sirolimus-Eluting Stent in
Unselected Patients with
Long Coronary Lesions:
LONG-FLEX Registry
5 Long term clinical International Vancouver, 10.13140/RG.2.1.1400.9760 2015
outcomes following Academy of Canada
sirolimus-eluting stent Cardiology,
implantation in diabetic 20th World
vs. non-diabetic patients Congress on
Heart
Disease, July
25-27, 2015
6 Clinical outcomes of ESC London - United 10.13140/RG.2.1.3440.2725 2015
successful percutaneous CONGRESS Kingdom
coronary intervention for 2015
chronic total occlusion
treated with sirolimus-
eluting stent: Results from
the multicenter CTO
registry

Page 15 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

7 In-hospital, thirty-day and ESC London - United 2015


six-month result of CONGRESS Kingdom
biodegradable polymer 2015
coated sirolimus eluting
stent in coronary artery
lesions (i-TRIAL study)
8 Evaluation of clinical and EuroPCR, 19- France 10.13140/2.1.1763.6644 2015
angiographic outcomes 22 May
with bioabsorbable
polymer coated sirolimus-
eluting stent in de novo
coronary artery disease:
Results of the MANIPAL-
FLEX first-in-man study
9 Clinical outcomes after EuroPCR, 19- France 10.13140/2.1.1501.5203 2015
implantation of 22 May
bioabsorbable polymer
coated sirolimus-eluting
stent in multivessel
stenting: 6-month follow-
up data from the
MULTIDOS study
10 In-hospital, thirty-day and EuroPCR, 19- France 10.13140/2.1.4909.3921 2015
six-month result of 22 May
biodegradable polymer
coated sirolimus eluting
stent in coronary artery
lesions (i-TRIAL study)
11 Clinical outcomes from EuroPCR, 19- France 10.13140/2.1.2812.2408 2015
unselected real-world 22 May
patients with long
coronary lesion receiving
40mm bioabsorbable
polymer coated sirolimus-
eluting stent
12 Evaluation of SCAI, May 6- USA 10.13140/2.1.4785.7448 2015
thienopyridine-resistance by 9
measuring platelet
aggregation in individuals
taking antiplatelet drugs
post-PCI: Outcomes with a
novel, FDA-approved, point-
of-care platelet aggregometer
“AggreGuide A-100”
13 One-year outcomes of SCAI, May 6- USA 10.13140/2.1.3475.0242 2015
Biodegradable Polymer- 9
Coated Sirolimus-Eluting

Page 16 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

Coronary Stent System in


Real-world Setting: Findings
of Indolimus Registry
14 Safety and efficacy of SCAI, May 6- USA 10.13140/2.1.2426.4487 2015
coronary intervention in 9
patients with Acute
Myocardial Infarction:
Outcomes of Sirolimus-
eluting stent in “All-comers”
Lesion Treatment
15 Carotid artery stenting ICCA Stroke Germany 10.13140/2.1.3866.9609 2015
without protection devices 2015
for the treatment of congress,
obstructive extracranial April 17-18
carotid artery disease:
Results from a large volume,
single-center study
16 The short-term and long- CRT, March USA 2009
term Clinical Outcomes 4-6
Following Coronary Stenting

From Google Scholar Dated: 31 Oct, 2018

 Editorial Reviewer
 Journal of Medical Devices: Evidence and Research (Dove Press)
 Indian Heart Journal (Elsevier)

Page 17 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

 Journal of Cardiology and Therapy


 International Journal of Clinical Medicine
 Editorial/Advisory Board Member
 Journal of Cardiology and Therapy
 Authors Identification No.:
 ORCID ID: 0000-0002-0051-4939
 Scopus Author ID: 56190516500
 National Advisory Board
 The Indus Foundation
 Guide for Research Studies/Ph.D.
 AMET University, Chennai
 Invited Guest Faculty
 National Institute of Pharmaceutical Education and Research (NIPER) , Ahmedabad
 Institute of Pharmacy – NIRMA University, Ahmedabad
 L M College of Pharmacy, Ahmedabad
PROFESSIONAL MEMBERSHIP
 American Medical Writer Association (Member ID – 59029742)
 European Medical Writers Association (Membership no. – 18386)
 ACRP- Member of Association of Clinical Research Professionals
 SoCRA- Member of Society of Clinical Research Associates
 ISCR- Member of Indian Society for Clinical Research (ISCR Annual membership number is 939)
 IPS- Member of Indian Pharmacological Society
 RAPS- Member of Regulatory Affairs Professionals Society
 SCAI-The Society for Cardiovascular Angiography and Interventions
 ESC- European Society of Cardiology
 TCTMD Platinum- The Transcatheter Cardiovascular Therapeutics
 ACC-American College of Cardiology
 ACE- Accreditation for Cardiovascular Excellence
 AIMED - Association of Medical Device Industry
 APVS – Asia Pacific Vascular Society
 ISMPP - The International Society for Medical Publication Professionals (Expiration: July 21, 2019)
 All India Medical Writers Association (AIMWA)

 INTERNATIONAL & NATIONAL CONFERENCES/MEETINGS/CERTIFICATE COURSE


ATTENDED
 Attended IndiaLive 2019, IACTSCON 2019 and EuroPCR 2019
 Attended IndiaValves 2018, Aorta2018.

Page 18 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

 Attended TCT 2018, held on 21-25 September, 2018 at San Diego, USA.
 Attended EuroPCR 2018, held on May 2018 Paris, France.
 Attended IACTSCON 2018, held on 1-4 Feb, 2018 at Vishakhapatnam, India.
 Attended ISCR 2018, held on 19-20, Jan 2018 at Bangalore, India
 Attended pre-conference workshop on Principles of Evidence Based Medicine and its applicability in India,
held on 17 Jan, 2018 at St. John’s Medical College, Bangalore, India
 Organized training on “Medical Writing and Literature Search” 13 Jan, 2018 at Meril Academy, Vapi, India.
 Attended TCT 2017, held on 29 Oct – 2 Nov, 2017 in Denver, USA.
 Attended EuroPCR 2017, held on 16-19 May, 2017 in Paris, France.
 Attended India Live 2017 held at New Delhi from March 2 nd- 4th, 2017 and awarded 3rd place for best E-
Poster Presentation.
 Attended TAVI and OCT Live Course on 1st March, 2017 at Medanta Heart Institute.
 Attended course on Structural Heart Disease Course on September 11, 2016 at CIMS, Ahmedabad.
 Attended EuroPCR 2016, held on 17-20 May, 2016 in Paris, France.
 Attended Certificate course by Elsevier Publishing Campus – “How do Editors look at your paper?” on 22 nd
September, 2015.
 Delivered talk on “Preparing Clinical Evaluation Report and Literature Search Report for Medical
Device”during conference on ‘Challenges in Design and Conduct of Clinical Trials of Medical Devices’,
held on 22 August, 2015 at Jamia Hamdard, Convention Center, Delhi.
 Attended TCTINDIANEXT 2015, held on 14-16 August, 2015 in Bangalore, India.
 Attended workshop on “Application of Statistical Software in Medical Research” from 5 th to 8th July, 2015
at ICPO (Institute of Cytology and Preventive Oncology), Noida.
 Attended 7th Asia Pacific Vascular Intervention Course/Fellows Course, 12 th -14th June, 2015 at New Delhi,
India
 Attended EuroPCR 2015, held on 19-22May, 2015 in Paris, France.
 Attended NIC Mid-Term Meet 2015 scheduled from 2-5 April 2015 at Taj Palace Hotel, New Delhi, India
 Attended India Live 2015 conference on February 25-28, 2015 at Chennai, India.
 Attended 12th National Conference on “Indian Medical Devices & Plastics Disposables / Implants Industry
2015" at Ahmedabad held on January 9-10, 2015
 Attended 66th annual conference Cardiological Society of India, 2014 on 4-7 December, 2014 at Hyderabad,
India.
 Attended TCTINDIANEXT 2014, held on August 2015 in Hyderabad, India.
 Attended 11th National Conference on “Indian Medical Devices & Plastics Disposables Industry 2014" at
Ahmedabad held on January 10-11, 2014

Page 19 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

 Attended a workshop on Medical Technologies MEDTEC 2013 at Mumbai held on 3-4 Oct 2013.
 Attended 10th National Conference on “Indian Medical Devices & Plastics Disposables Industry 2013" at
Ahmedabad held on January 9-10, 2013
 Attended a workshop on Medical Devices and Plastics at Ahmedabad held on March, 2012.
 Attended EuroPCR 2011, Paris, France.
 Attended a workshop on Medical Devices Regulations sponsored by CDSCO and WHO at Chennai held on
9-10 December, 2011.
 Participated as a Faculty at the workshop on “Application of SPSS in Pharmaceutical Sciences” held on 24 th
April 2011 at L. M. College of Pharmacy, Ahmedabad.
 Attended a workshop on Medical Devices Regulations sponsored by CDSCO and WHO at B. V. Patel
PERD Centre, Ahmedabad held on 18-19 March, 2011.
 Attended a conference on “Biomaterials, Tissue Engineering and Drug Delivery Systems” during February
10-12, 2011 by INDO-AUSTRALIAN Conference at Vallabh Vidyanagar, Gujarat.
 Attended a training workshop on “Clinical Trials and Statistical Computing” during 15-19 March, 2010 by
National Institute of Medical Statistics (Indian Council of Medical Research) at New Delhi.
 Attended UGC sponsored National Workshop on “Medicinal and Pharmaceutical Statistics” organized by
the dept. of statistics, Sardar Patel University, Vallabh Vidyanagar during 25-28 February, 2010.
 Attended IPSCON, 2009 on December 10 – December 12, 2009 at Kolkata, India.
 Attended IPS, 2008 on December 18 – December 20, 2008 at New Delhi, India.
 Attended 59th annual conference CSI, 2007 on 6-9 December, 2007 at Hyderabad, India.
 Attended Clinical Excellence Program on GCP conducted on 06th Oct 2007 by Sanofi Aventis.
 Attended Investigator’s Meeting: OASIS 7 Study on Mar 31 – April 1, 2007 at Banglore, India.
 Attended Investigator’s Meeting: PROTECT Study on 22, April 2007, Ahmedabad, India.
 Attended the “workshop on Good Laboratory Practices For Academia, Sponsored by Department of
Sciences and Technology, Government of India” 24th and 25th November 2006, at the All India Institute of
Medical Sciences, New Delhi, India.
 Participated in International Diabetic Conference, Sponsored by Zydus-Cadila Pharma Ltd., Ahmedabad
held on 1-4 February, 2007.

 ACADEMIC BACKGROUND

Degree/Examinations Year Board/University Subjects/Specialization % of marks

SSC 1993 Gujarat Education Board Science 68


HSC 1995 Gujarat Education Board Science 66
D. Pharmacy 1997 Gujarat University Pharmacy 62

Page 20 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

B. Pharmacy 2000 S.R.T.M. Uni. Pharmacy 70


M.B.A. 2002 North Guj. Uni. Marketing 58
Master of Pharmacy 2007 S. P. University Clinical Pharmacy 68
Statistical Package for the 2011 S. P. University Biostatistics 60
Social Sciences (SPSS)
Ph.D 2012 Gujarat University Clinical Pharmacology NA

 PERSONAL PROFILE
Full Name: Ashokkumar Suryakant Thakkar
Date of Birth: 13 November, 1977
Present Address: F-802, Pramukh Residency, Nr. Gram Panchayat Office, Chala, Vapi-396191, Gujarat.
Mobile No:
Skype: (+91) 9879443584
asthakkar1
Languages known: English, Hindi and Gujarati
Email ID: drashokthakkar@gmail.com, ashokmba2000@gmail.com
Linkedin Profile: http://in.linkedin.com/in/ashokthakkar
Researchgate
Profile: https://www.researchgate.net/profile/Ashok_Thakkar2
Countries Visited: USA, France, Italy, South Korea, Iran, Saudi Arabia, Oman
Current Team Size: 80 Team Members

Skills/Qualifications: · Ability to strategically and effectively communicate with cross-functional


colleagues, internal leadership, and external professionals to appropriately convey
essential information and ensure favorable project outcomes.

· Effective written and verbal communication skills in the area of


technical/clinical applications. Strong command of medical and surgical
terminology.

· Demonstrated ability to identify problems, perform basic root cause


analyses, and propose effective solutions.

· Ability to coordinate and lead multiple projects simultaneously.


· Ability to establish and maintain collaborative working relationships with
internal and external team members

· Ability to appropriately apply different standards related to medical devices/


clinical research (SOPs, GCP, ISO, ICH, FDA, MEDDEV etc.).

· Effective knowledge in searching medical literature and scientific databases


for clinical and technical information.

· Familiarity with clinical biostatistics techniques and methods.

· Ability to train, motivates, and develops others to promote team and

Page 21 of 22
Dr. Ashok Thakkar
E-mail: drashokthakkar@gmail.com Cell: +91-9879443584

departmental alignment.

· Ability to work with a minimum of supervision.

· Ability to work in a highly matrixed team environment.

· Effectively anticipate and adjusts to changes and uncertainties, able to


project future trends and issues.

· Demonstrate aptitude for achieving goals through understanding of process,


ability to prioritize, and internal drive for results.

Page 22 of 22

You might also like